Study Conduct

European patient engagement in critical condition

Thursday, October 15, 2015

Western Europe boasts one of the largest and most active markets for clinical trials. Indeed, more than one in five active clinical investigators is based in Western Europe, and the growth in sponsor spending there now outpaces that in the U.S.

[Read More]

OSU joins PCORnet for healthcare delivery

Monday, October 5, 2015

The Patient-Centered Outcomes Research Institute (PCORI) has awarded the Ohio State University (OSU) College of Medicine and other Patient-Centered Network of Learning Health Systems members—including partners across six states and nine academic medical centers, healthcare systems, public health departments and private health plans—a three-year, $8.6 million grant to participate in a large, national collaborative initiative conducting clinical research more quickly and less expensively.

[Read More]

Prometheus gets NIH grant for biomedical and behavioral research

Monday, October 5, 2015

Prometheus Research has been awarded more than $250,000 from the NIH to transform the way electronic data capture (EDC) forms are configured, integrated and shared for biomedical and behavioral health research. The grant, part of NIH’s Small Business Innovation Research (SBIR) program, seeks to empower mental health researchers to easily share, reuse and locate electronic data capture forms across a variety of EDC platforms.

[Read More]

Group seeks greater diversity in clinical research

Thursday, October 1, 2015

First of two parts

In 2006, a trial led to a “black box warning label” for an asthma medi­cation found to have a disproportion­ally increased death rate. It revealed that respiratory-related deaths oc­curred four times more often in Af­rican-Americans who took the drug.

[Read More]

Symbiodx, Cure Forward partner on precision medicine

Wednesday, September 30, 2015

Symbiodx, a molecular reference laboratory in the Pacific Northwest, and Cure Forward, a Cambridge, Mass.-based, multisided technology platform to support patient engagement, are collaborating to advance precision medicine. The partnership will provide patients with streamlined access to their genomic data and greater exposure to relevant clinical trials.

[Read More]

WCG, PCCTC partner to improve oncology research reviews

Tuesday, September 29, 2015

WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services and software to support clinical research, and the Prostate Cancer Clinical Trials Consortium (PCCTC), a multicenter clinical research organization specializing in cutting-edge prostate cancer research, have formed a new partnership to enhance the quality and efficiency of the consortium’s research review process.

[Read More]